Clinical Trial: SWOG S0931

SWOG S0931

Status: Closed

NCT#01120249

EVEREST: EVErolimus for Renal Cancer Ensuing Surgical Therapy, A Phase III Study

S0931 has met its accrual goal and is permanently closed to accrual effective September 15, 2016 at 11:59 p.m. Pacific Time.

The Montana Cancer Consortium (MCC) is an independent nonprofit organization whose mission is to bring state-of-the-art cancer care to Montana, Idaho and Wyoming through National Cancer Institute (NCI) sponsored clinical research.

Navigation

About Us

Contact Us

Copyright © Montana Cancer Consortium | All rights reserved